You may also like
Hemoadsorption Eliminates Remdesivir from the Circulation: Implications for the Treatment Of COVID-19
Remdesivir and its main active metabolite GS‐441524 are rapidly eliminated from the perfusate by the CytoSorb® adsorber device in vitro. This should be considered in patients for whom both therapies are indicated, and simultaneous application should be avoided. In general, plasma levels of therapeutic drugs should be closely monitored under concurrent CytoSorb® therapy.
1 min read
Patient Blood Management During the COVID‐19 Pandemic ‐ a Narrative Review
This review considers the impact of the COVID‐19 pandemic on the blood supply and specifies important aspects of donor management.
1 min read
Effectiveness of Preoperative Autologous Plateletpheresis Combined With Intraoperative Autotransfusion on the Blood Coagulation in Orthopaedic Patients
To investigate the effectiveness of preoperative plateletpheresis combined with intraoperative autotransfusion on the blood coagulation of orthopaedic patients.
1 min read